628332-29-6

Upstream product

• 235091-20-0 4-(benzyloxy)-1-bromo-2-(methoxymethoxy)benzene 
• 74-88-4 methyl iodide 
• 70120-19-3 5-(benzyloxy)-2-bromophenol 
• 52085-14-0 4-benzoxy-salicylaldehyde 
• 3769-41-3 3-Benzyloxyphenol 

Downstream Products

• 628332-32-1 ethyl 2-(3-hydroxy-4-methylphenoxy)-2-methylpropanoate 
• 628332-31-0 ethyl 2-[3-(methoxymethoxy)-4-methylphenoxy]-2-methylpropanoate 
• 628332-30-9 3-(methoxymethoxy)-4-methylphenol 

Relevant academic research and scientific papers

1,2-AZOLE DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY

A compound represented by the formula (1) wherein ring A is a ring optionally having 1 to 3 substituents; ring B is a 1,2-azole ring which may further have 1 to 3 substituents; Xa, Xb and Xc are the same or different and each is a bond, - O -, - S - and the like; Ya is a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; Yb and Yc are the same or different and each is a bond or a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; ring C is a monocyclic aromatic ring which may further have 1 to 3 substituents; and R represents -OR4 (R4 is hydrogen atom or optionally substituted hydrocarbon group) and the like, or a salt thereof or a prodrug thereof is useful as an agent for the prophylaxis or treatment of diabetes and the like.

Regioselective lithiation of resorcinol derivatives: Synthesis of mono O-MOM- and O-benzylresorcinols prenylated at C-2 or C-4 positions

Resorcinol derivatives 3-benzyloxy-1-methoxymethoxybenzene (3b) and 4- benzyloxy-1-bromo-2-methoxymethoxybenzene (3c) were regioselectively lithiated. The resulting aryllithium intermediates or their cuprate derivatives were reacted with allyl bromide (4a